Literature DB >> 28341439

Restoring pulmonary surfactant membranes and films at the respiratory surface.

Mercedes Echaide1, Chiara Autilio1, Raquel Arroyo1, Jesus Perez-Gil2.   

Abstract

Pulmonary surfactant is a complex of lipids and proteins assembled and secreted by the alveolar epithelium into the thin layer of fluid coating the respiratory surface of lungs. There, surfactant forms interfacial films at the air-water interface, reducing dramatically surface tension and thus stabilizing the air-exposed interface to prevent alveolar collapse along respiratory mechanics. The absence or deficiency of surfactant produces severe lung pathologies. This review describes some of the most important surfactant-related pathologies, which are a cause of high morbidity and mortality in neonates and adults. The review also updates current therapeutic approaches pursuing restoration of surfactant operative films in diseased lungs, mainly through supplementation with exogenous clinical surfactant preparations. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribá.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ARDS; Air-liquid interface; Exogenous surfactant therapy; Meconium aspiration sindrome; NRDS; Respiratory mechanics

Mesh:

Substances:

Year:  2017        PMID: 28341439     DOI: 10.1016/j.bbamem.2017.03.015

Source DB:  PubMed          Journal:  Biochim Biophys Acta Biomembr        ISSN: 0005-2736            Impact factor:   3.747


  23 in total

1.  Functional Genomics of ABCA3 Variants.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff Luke; Fuhai Li; Frances V White; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 2.  Surfactant protein D and bronchopulmonary dysplasia: a new way to approach an old problem.

Authors:  Raquel Arroyo; Paul S Kingma
Journal:  Respir Res       Date:  2021-05-08

3.  Controlled hypothermia may improve surfactant function in asphyxiated neonates with or without meconium aspiration syndrome.

Authors:  Chiara Autilio; Mercedes Echaide; Daniele De Luca; Jesús Pérez-Gil
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 4.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

5.  Inhibition and counterinhibition of Surfacen, a clinical lung surfactant of natural origin.

Authors:  Yuliannis Lugones; Odalys Blanco; Elena López-Rodríguez; Mercedes Echaide; Antonio Cruz; Jesús Pérez-Gil
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

6.  Recombinant Human Superoxide Dismutase and N-Acetylcysteine Addition to Exogenous Surfactant in the Treatment of Meconium Aspiration Syndrome.

Authors:  Jana Kopincova; Maros Kolomaznik; Pavol Mikolka; Petra Kosutova; Juliana Topercerova; Katarina Matasova; Andrea Calkovska; Daniela Mokra
Journal:  Molecules       Date:  2019-03-05       Impact factor: 4.411

7.  Pulmonary surfactant and drug delivery: Vehiculization, release and targeting of surfactant/tacrolimus formulations.

Authors:  Alberto Hidalgo; Cristina Garcia-Mouton; Chiara Autilio; Pablo Carravilla; Guillermo Orellana; Mohammad N Islam; Jahar Bhattacharya; Sunita Bhattacharya; Antonio Cruz; Jesús Pérez-Gil
Journal:  J Control Release       Date:  2020-11-24       Impact factor: 9.776

Review 8.  The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19.

Authors:  Shengguang Wang; Zhen Li; Xinyu Wang; Shiming Zhang; Peng Gao; Zuorong Shi
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

9.  Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice.

Authors:  Jens Madsen; Madhuriben H Panchal; Rose-Marie A Mackay; Mercedes Echaide; Grielof Koster; Giancarlo Aquino; Nicola Pelizzi; Jesus Perez-Gil; Fabrizio Salomone; Howard W Clark; Anthony D Postle
Journal:  J Lipid Res       Date:  2018-08-14       Impact factor: 5.922

10.  The Influence of BuqiHuoxueTongluo Formula on Histopathology and Pulmonary Function Test in Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats.

Authors:  Xiaolin Yu; Yanxia Zhang; Xiaohua Yang; Xiaomei Zhang; Xinxiang Wang; Xuemei Liu; Yan Yan
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.